Wellington Management Group
JBIO

Wellington Management Group’s Jade Biosciences JBIO Stock Holding History

Wellington Management Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
90,396
-38,770
-30% -$809K ﹤0.01% 1623
2026
Q1 		$1.81M Buy
129,166
+26,546
+26% +$384K ﹤0.01% 1569
2025
Q4 		$1.58M Sell
102,620
-4,933
-5% -$57.9K ﹤0.01% 1645
2025
Q3 		$928K Buy
+107,553
New +$879K ﹤0.01% 1792

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group's JBIO Position: Q2 2026 in Review

Wellington Management Group reduced its Jade Biosciences (JBIO) stake by 30% in Q2 2026, selling an estimated $809K and leaving 90,396 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Wellington Management Group first reported a position in JBIO in Q3 2025 and has held it in 4 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Wellington Management Group held 90,396 shares of Jade Biosciences worth $2.01M as of Q2 2026.
  • Wellington Management Group sold 38,770 Jade Biosciences shares in Q2 2026, an estimated $809K.
  • Jade Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1623 holding.
  • Wellington Management Group first reported a position in Jade Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.